|
|||||
|
|
Cancer screening in the United States, 2018: A review of current American Cancer Society guidelines and current issues in cancer screening |
|
| Authors: | Robert A. Smith PhD Kimberly S. Andrews BA Durado Brooks MD MPH Stacey A. Fedewa PhD MPH Deana Manassaram‐Baptiste PhD MPH Debbie Saslow PhD Otis W. Brawley MD Richard C. Wender MD |
| Affiliation: | 1. Vice President, Cancer Screening, Cancer Control Department, American Cancer Society, Atlanta, GA;2. Director, Guidelines Process, Cancer Control Department, American Cancer Society, Atlanta, GA;3. Vice President, Cancer Control Interventions, Cancer Control Department, American Cancer Society, Atlanta, GA;4. Strategic Director for Risk Factors & Screening Surveillance, Department of Epidemiology and Research Surveillance, American Cancer Society, Atlanta, GA;5. Senior Director, HPV Related and Women's Cancers, Cancer Control Department, American Cancer Society, Atlanta, GA;6. Chief Medical Officer, American Cancer Society, Atlanta, GA;7. Chief Cancer Control Officer, American Cancer Society, Atlanta, GA. |
| Abstract: | Each year, the American Cancer Society publishes a summary of its guidelines for early cancer detection, data and trends in cancer screening rates from the National Health Interview Survey, and select issues related to cancer screening. In this 2018 update, we also summarize the new American Cancer Society colorectal cancer screening guideline and include a clarification in the language of the 2013 lung cancer screening guideline. CA Cancer J Clin 2018;68:297–316 . © 2018 American Cancer Society . |
| Keywords: | breast neoplasms cervical neoplasms colorectal neoplasms lung neoplasms mass screening ovarian neoplasms prevention and control prostate neoplasms |